In October 2022 the India National Anti-Doping Agency (INADA) has reported an anti-doping rule violation against the Athlete Mohd Arshlan after his sample tested positive for the prohibited substances Metandienone and Stanazolol.
Following notification a provisional suspension was ordered and the Athlete was heard for the Anti-Doping Disciplinary Panel of India (ADDPI).
The Athlete admitted the violation and acknowledged that he knowingly had received an injection to enhance his sport performance on advice of another athlete.
The Panel finds that the presence of the prohibited substances has been established and accordingly that he committed an anti-doping rule violation.
Therefore the Panel decides on 28 March 2023 to impose a 4 year period of inelgibility on the Athlete, starting on the date of the provisional suspension, i.e. on 21 October 2022.
